NCT03106610 2018-05-24Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG ImmunotherapyM.D. Anderson Cancer CenterPhase 1 Terminated1 enrolled